GMED vs DXCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Apr 04, 2026

GMED

64.2
AI Score
VS
GMED Wins

DXCM

46.7
AI Score

Investment Advisor Scores

GMED

64score
Recommendation
BUY

DXCM

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GMED DXCM Winner
Forward P/E 19.3424 25.1889 GMED
PEG Ratio 1.7253 1.3717 DXCM
Revenue Growth 25.7% 13.1% GMED
Earnings Growth 437.0% 78.0% GMED
Tradestie Score 64.2/100 46.7/100 GMED
Profit Margin 18.3% 17.9% GMED
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD GMED

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.